|
| 1 |
|
Conditions listed in this trial |
|
|
Graft Versus Host Disease |
|
|
Kidney Cancer |
|
|
Leukemia |
|
|
Lymphoma |
|
|
Myelodysplastic Syndromes |
|
|
Neuroblastoma |
|
|
Ovarian Cancer |
|
|
Sarcoma |
|
|
Testicular Germ Cell Tumor |
|
| 2 |
|
Additional conditions recognized in this trial |
|
|
Carcinoma, Renal Cell |
|
|
Graft vs Host Disease |
|
|
Kidney Neoplasms |
|
|
Multiple Myeloma |
|
|
Myelodysplastic-Myeloproliferative Diseases |
|
|
Myeloproliferative Disorders |
|
|
Neoplasms |
|
|
Neoplasms, Germ Cell and Embryonal |
|
|
Neoplasms, Plasma Cell |
|
|
Ovarian Neoplasms |
|
|
Preleukemia |
|
|
Syndrome |
|
| 3 |
|
More general conditions related to this trial |
|
|
Adenocarcinoma |
|
|
Adnexal Diseases |
|
|
Blood Protein Disorders |
|
|
Bone Marrow Diseases |
|
|
Carcinoma |
|
|
Cardiovascular Diseases |
|
|
Disease |
|
|
Endocrine Gland Neoplasms |
|
|
Endocrine System Diseases |
|
|
Genital Diseases, Female |
|
|
Genital Neoplasms, Female |
|
|
Gonadal Disorders |
|
|
Hematologic Diseases |
|
|
Hemorrhagic Disorders |
|
|
Hemostatic Disorders |
|
|
Immune System Diseases |
|
|
Immunoproliferative Disorders |
|
|
Kidney Diseases |
|
|
Lymphatic Diseases |
|
|
Lymphoproliferative Disorders |
|
|
Neoplasms by Histologic Type |
|
|
Neoplasms by Site |
|
|
Neoplasms, Glandular and Epithelial |
|
|
Neoplasms, Nerve Tissue |
|
|
Neoplasms, Neuroepithelial |
|
|
Neuroectodermal Tumors |
|
|
Neuroectodermal Tumors, Primitive |
|
|
Neuroectodermal Tumors, Primitive, Peripheral |
|
|
Ovarian Diseases |
|
|
Paraproteinemias |
|
|
Pathologic Processes |
|
|
Precancerous Conditions |
|
|
Urogenital Neoplasms |
|
|
Urologic Diseases |
|
|
Urologic Neoplasms |
|
|
Vascular Diseases |
|
| 4 |
|
Interventions listed in this trial |
|
|
therapeutic allogeneic lymphocytes |
|
| 5 |
|
Sponsors listed in this trial |
|
|
Fred Hutchinson Cancer Research Center |
|
|
National Cancer Institute (NCI) |
